NCT03119883 2024-08-09
Dysregulation of Glutamine Activity in the Pathogenesis of Multiple Myeloma
Mayo Clinic
Phase NA Completed
Mayo Clinic
G1 Therapeutics, Inc.
Virginia Commonwealth University
St. Petersburg State Pavlov Medical University
British Columbia Cancer Agency
University of California, San Diego
University of Reading
Instituto Nacional de Cancer, Brazil
McGill University Health Centre/Research Institute of the McGill University Health Centre